1.00 / AMA PRA Category 1 CreditTM 1.00 / CNE Contact Hour
This activity is jointly provided by Haymarket Medical Education (HME) and AKH Inc., Advancing Knowledge in Healthcare (AKH).
Supported by an educational grant from Edwards Lifesciences LLC
Aortic stenosis is relatively common in older adults. Once symptoms develop, the condition is rapidly fatal without treatment. Effective therapy historically has involved surgical aortic valve replacement (SAVR), an intervention for which many patients were not candidates due to surgical risk. Transcatheter aortic valve replacement (TAVR) has revolutionized the treatment of aortic stenosis, demonstrating equivalence or benefit compared with surgery for an ever-growing range of patients. It is now guideline-recommended for patients at prohibitive and high surgical risk, is a recommended option in those at intermediate risk, and has demonstrated benefit in those at low surgical risk. Despite these advances, untreated aortic stenosis is common and many clinicians remain unaware of the benefits of TAVR and how to identify candidates for TAVR and SAVR. This roundtable features a leading cardiac surgeon and a noted interventional cardiologist with a prominent clinical cardiologist reviewing the lastest data about TAVR and SAVR along with when to recommend each procedure.
Cardiologists and cardiology nurses, nurse practitioners (NPs), physician assistants (PAs), and other clinicians (including primary care physicians, vascular surgeons, and interventional radiologists) who manage and treat patients with heart valve pathology
After completing the activity, the participant should be better able to:
Recognize the prevalence and clinical impact of aortic stenosis
Identify patients, including those at relatively low surgical risk, who may benefit from TAVR vs traditional surgical approaches
Describe the findings of recent clinical trials and registry analyses of TAVR vs SAVR in both tricuspid and bicuspid disease
Define ongoing concerns and controversies in long-term management of patients who have undergone TAVR
Conflict Of Interest Disclosure Policies
In accordance with the ACCME Standards for Commercial Support, HME and AKH require that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. HME and AKH resolve all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational activities.
Christopher Cannon, MD Education Director, Cardiovascular Innovation Preventive Cardiology Section Brigham and Women’s Hospital Professor of Medicine, Harvard Medical School Boston, MA
Dr. Cannon receives consulting fees from Aegerion Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., Amarin Corporation, Amgen Inc., Boehringer Ingelheim, Bristol-Myers Squibb, Corvidia Therapeutics, Eisai Co., Ltd., Innovent Biologics, Inc., Janssen, Kowa Pharmaceuticals Inc., Merck & Co. Inc., Pfizer Inc., Regeneron Pharmaceuticals Inc., and Sanofi US. He also receives grant support from Amgen Inc., Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Janssen, and Merck & Co., Inc.
Pinak Bipin Shah, MD Director, Cardiac Catheterization Lab Assistant Professor, Cardiovascular Medicine Harvard Medical School Division of Cardiovascular Medicine Brigham and Women’s Hospital Boston, MA
Dr. Shah receives consulting fees from Edwards Lifesciences LLC.
Vinod H. Thourani, MD, FACS, FACC Professor of Surgery Georgetown University School of Medicine Chair, Department of Cardiac Surgery Medstar Heart and Vascular Institute Washington, DC
Dr. Thourani receives consulting fees from Abbott, Boston Scientific Corporation, Edwards Lifesciences LLC, and W.L. Gore and Associates. He also receives grant support from Abbott, Boston Scientific Corporation, Edwards Lifesciences LLC, and JenaValve Technology Inc.
Accredited Provider Disclosure
Haymarket Medical Education and AKH Inc., Advancing Knowledge in Healthcare staff involved in the planning and review of this activity have no relevant financial relationships to disclose.
Dorothy Caputo, MA, BSN, RN, Lead Nurse Planner for AKH Inc., Advancing Knowledge in Healthcare has no relevant financial relationships to disclose.
AMA PRA Category 1 Credit(s)TM
Haymarket Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Haymarket Medical Education designates this enduring material for a maximum of 1.00 AMA PRA Category 1 CreditTM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE Contact Hour(s)
AKH Inc., Advancing Knowledge in Healthcare is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
This activity is awarded 1.00 contact hour.
Additional Credit Information
Physician Assistant Continuing Education The American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 CreditTM from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 1.00 Category 1 Credit for completing this activity.
Nurse Practitioner Continuing Education The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 CreditTM from organizations accredited by ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.
Disclosure of Unlabeled Use
This CME/CE activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME/CE activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options for a specific patient’s medical condition.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Haymarket Medical Education, AKH Inc., Advancing Knowledge in Healthcare, or Edwards Lifesciences LLC. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
To obtain credit, a score of 70% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME™ within your Profile/CME History, which you can access at any time.